13:27 EDT OncoCyte (OCX) files to sell 10.61M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCX:
- OncoCyte’s Strategic Positioning and Growth Potential in Transplant Rejection Testing
- OncoCyte initiated with a Buy at Lake Street
- OncoCyte Corp’s Positive Earnings Call Highlights Growth
- OncoCyte reports Q4 EPS ($1.93) vs. ($1.96) last year
- Positive Outlook on OncoCyte’s Stock Due to Strategic Launch and Financial Management